FDG PET-CT in Advanced Breast Cancer

This study is a prospective cohort study comparing metabolic response evaluation by F-18 FDG PET-CT versus conventional imaging for outcome stratification in patients with advanced breast cancer receiving first-line systemic therapy.

Trial Details

NCT ID
NCT07173868
Sponsor
Samsung Medical Center
Status
RECRUITING
Cancer Type
Breast Cancer
Locations (sample)
  • Seoul, Gannam-gu, South Korea

Key Eligibility Criteria

  • 19 years of age or older
  • histologically confirmed metastatic or locally advanced breast cancer with no radical topical treatment available
  • If there is liver metastasis, which the researcher believes will be difficult to evaluate the response accurately with bone metastasis or CT
  • May or may not have measurable lesions in accordance with RECIST 1.1 criteria

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →